The effect of isoniazid on BCG-induced toxicity in patients with superficial bladder cancer

European Urology

Volumn 37, Issue SUPPL. 1, 2000, Pages 26-30

  Al Khalifa, M ^a   Elfving, P ^a   Mansson W ^a   Colleen, Stig ^a   Hellsten, S ^a   Duchek, M ^b   Nyberg, G ^c   Callaghan, P ^d   Rademark, C ^e   Eriksson, R ^f   Olsson, R ^g   Hagberg, G ^h   Nelson, C E ⁱ  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c University Hospitals of Umeå ^*  (Sweden)

^d County Hospitals of Boden ^*  (Sweden)

^e County Hospitals of Halmstad ^*  (Sweden)

^f County Hospitals of Helsingborg ^*  (Sweden)

^g County Hospitals of Karlshamn ^*  (Sweden)

^h County Hospitals of Trelleborg ^*  (Sweden)

ⁱ County Hospitals of Växjö ^*  (Sweden)

Author keywords

BCG toxicity; BCG vaccine; Bladder cancer; Bladder contraction; INH prophylaxis; Isoniazid

Indexed keywords

BCG VACCINE; ISONIAZID;

ADULT; AGED; BLADDER CANCER; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FEVER; FOLLOW UP; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; TRANSITIONAL CELL CARCINOMA;

EID: 0033955329     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052379     Document Type: Conference Paper

References (23)